Europe Neurological Disorder Drugs Market Report 2017

January 2017 | 105 pages | ID: E347FFFF1F4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neurological Disorder Drugs

Revenue, means the sales value of Neurological Disorder Drugs

This report studies sales (consumption) of Neurological Disorder Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Neurological Disorder Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Split by application, this report focuses on sales, market share and growth rate of Neurological Disorder Drugs in each application, can be divided into

• Hospital
• Clinic
• Home

Contents

Europe Neurological Disorder Drugs Market Report 2017

1 NEUROLOGICAL DISORDER DRUGS OVERVIEW

1.1 Product Overview and Scope of Neurological Disorder Drugs
1.2 Classification of Neurological Disorder Drugs
  1.2.1 Antipsychotic
  1.2.2 Hypnotic & Sedative
  1.2.3 Analgesics
  1.2.4 Anticoagulants
  1.2.5 Others
1.3 Application of Neurological Disorder Drugs
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home
1.4 Neurological Disorder Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Neurological Disorder Drugs (2011-2021)
  1.5.1 Europe Neurological Disorder Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE NEUROLOGICAL DISORDER DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Neurological Disorder Drugs Market Competition by Manufacturers
  2.1.1 Europe Neurological Disorder Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Neurological Disorder Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Neurological Disorder Drugs (Volume and Value) by Type
  2.2.1 Europe Neurological Disorder Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Neurological Disorder Drugs (Volume and Value) by Countries
  2.3.1 Europe Neurological Disorder Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Neurological Disorder Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Neurological Disorder Drugs (Volume) by Application

3 GERMANY NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Neurological Disorder Drugs Sales and Value (2011-2016)
  3.1.1 Germany Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Neurological Disorder Drugs Sales Price Trend (2011-2016)
3.2 Germany Neurological Disorder Drugs Sales and Market Share by Manufacturers
3.3 Germany Neurological Disorder Drugs Sales and Market Share by Type
3.4 Germany Neurological Disorder Drugs Sales and Market Share by Application

4 FRANCE NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Neurological Disorder Drugs Sales and Value (2011-2016)
  4.1.1 France Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Neurological Disorder Drugs Sales Price Trend (2011-2016)
4.2 France Neurological Disorder Drugs Sales and Market Share by Manufacturers
4.3 France Neurological Disorder Drugs Sales and Market Share by Type
4.4 France Neurological Disorder Drugs Sales and Market Share by Application

5 UK NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Neurological Disorder Drugs Sales and Value (2011-2016)
  5.1.1 UK Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Neurological Disorder Drugs Sales Price Trend (2011-2016)
5.2 UK Neurological Disorder Drugs Sales and Market Share by Manufacturers
5.3 UK Neurological Disorder Drugs Sales and Market Share by Type
5.4 UK Neurological Disorder Drugs Sales and Market Share by Application

6 RUSSIA NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Neurological Disorder Drugs Sales and Value (2011-2016)
  6.1.1 Russia Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Neurological Disorder Drugs Sales Price Trend (2011-2016)
6.2 Russia Neurological Disorder Drugs Sales and Market Share by Manufacturers
6.3 Russia Neurological Disorder Drugs Sales and Market Share by Type
6.4 Russia Neurological Disorder Drugs Sales and Market Share by Application

7 ITALY NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Neurological Disorder Drugs Sales and Value (2011-2016)
  7.1.1 Italy Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Neurological Disorder Drugs Sales Price Trend (2011-2016)
7.2 Italy Neurological Disorder Drugs Sales and Market Share by Manufacturers
7.3 Italy Neurological Disorder Drugs Sales and Market Share by Type
7.4 Italy Neurological Disorder Drugs Sales and Market Share by Application

8 SPAIN NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Neurological Disorder Drugs Sales and Value (2011-2016)
  8.1.1 Spain Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Neurological Disorder Drugs Sales Price Trend (2011-2016)
8.2 Spain Neurological Disorder Drugs Sales and Market Share by Manufacturers
8.3 Spain Neurological Disorder Drugs Sales and Market Share by Type
8.4 Spain Neurological Disorder Drugs Sales and Market Share by Application

9 BENELUX NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Neurological Disorder Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Neurological Disorder Drugs Sales Price Trend (2011-2016)
9.2 Benelux Neurological Disorder Drugs Sales and Market Share by Manufacturers
9.3 Benelux Neurological Disorder Drugs Sales and Market Share by Type
9.4 Benelux Neurological Disorder Drugs Sales and Market Share by Application

10 EUROPE NEUROLOGICAL DISORDER DRUGS MANUFACTURERS ANALYSIS

10.1 Novartis AG
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.1.2.1 Antipsychotic
    10.1.2.2 Hypnotic & Sedative
  10.1.3 Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline plc
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.2.2.1 Antipsychotic
    10.2.2.2 Hypnotic & Sedative
  10.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck & Co.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.3.2.1 Antipsychotic
    10.3.2.2 Hypnotic & Sedative
  10.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Bayer AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.4.2.1 Antipsychotic
    10.4.2.2 Hypnotic & Sedative
  10.4.3 Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 AstraZeneca
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.5.2.1 Antipsychotic
    10.5.2.2 Hypnotic & Sedative
  10.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim GmbH
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.6.2.1 Antipsychotic
    10.6.2.2 Hypnotic & Sedative
  10.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Teva Pharmaceutical Industries Ltd.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.7.2.1 Antipsychotic
    10.7.2.2 Hypnotic & Sedative
  10.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 F. Hoffmann-La Roche Ltd.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Neurological Disorder Drugs Product Type, Application and Specification
    10.8.2.1 Antipsychotic
    10.8.2.2 Hypnotic & Sedative
  10.8.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 NEUROLOGICAL DISORDER DRUGS MANUFACTURING COST ANALYSIS

11.1 Neurological Disorder Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neurological Disorder Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Neurological Disorder Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Neurological Disorder Drugs Sales Forecast (2016-2021)
14.2 France Neurological Disorder Drugs Sales Forecast (2016-2021)
14.3 UK Neurological Disorder Drugs Sales Forecast (2016-2021)
14.4 Russia Neurological Disorder Drugs Sales Forecast (2016-2021)
14.5 Italy Neurological Disorder Drugs Sales Forecast (2016-2021)
14.6 Spain Neurological Disorder Drugs Sales Forecast (2016-2021)
14.7 Benelux Neurological Disorder Drugs Sales Forecast (2016-2021)
14.8 Europe Neurological Disorder Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Neurological Disorder Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Disorder Drugs
Table Classification of Neurological Disorder Drugs
Figure Europe Sales Market Share of Neurological Disorder Drugs by Type in 2015
Figure Antipsychotic Picture
Figure Hypnotic & Sedative Picture
Figure Analgesics Picture
Figure Anticoagulants Picture
Figure Others Picture
Table Application of Neurological Disorder Drugs
Figure Europe Sales Market Share of Neurological Disorder Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Home Examples
Figure Germany Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure France Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure UK Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Neurological Disorder Drugs Sales and Growth Rate (2011-2021)
Figure Europe Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Table Europe Neurological Disorder Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Neurological Disorder Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neurological Disorder Drugs Sales Share by Manufacturers
Figure 2016 Neurological Disorder Drugs Sales Share by Manufacturers
Table Europe Neurological Disorder Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Neurological Disorder Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Neurological Disorder Drugs Revenue Share by Manufacturers
Table 2016 Europe Neurological Disorder Drugs Revenue Share by Manufacturers
Table Europe Neurological Disorder Drugs Sales and Market Share by Type (2011-2016)
Table Europe Neurological Disorder Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure Europe Neurological Disorder Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Neurological Disorder Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure Europe Neurological Disorder Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Neurological Disorder Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Neurological Disorder Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Countries (2011-2016)
Table Europe Neurological Disorder Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Neurological Disorder Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Neurological Disorder Drugs by Countries (2011-2016)
Table Europe Neurological Disorder Drugs Sales and Market Share by Application (2011-2016)
Table Europe Neurological Disorder Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Application (2011-2016)
Figure Germany Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Germany Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Germany Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table Germany Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table Germany Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table Germany Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure France Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure France Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure France Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table France Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table France Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table France Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table France Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table France Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table France Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure UK Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure UK Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure UK Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table UK Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table UK Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table UK Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table UK Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table UK Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure Russia Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Russia Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Russia Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table Russia Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table Russia Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table Russia Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure Italy Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Italy Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Italy Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table Italy Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table Italy Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table Italy Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure Spain Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Spain Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Spain Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table Spain Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table Spain Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table Spain Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Figure Benelux Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Benelux Neurological Disorder Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Neurological Disorder Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Neurological Disorder Drugs Sales by Type (2015 and 2016)
Table Benelux Neurological Disorder Drugs Market Share by Type (2015 and 2016)
Table Benelux Neurological Disorder Drugs Sales by Application (2015 and 2016)
Table Benelux Neurological Disorder Drugs Market Share by Application (2015 and 2016)
Table Neurological Disorder Drugs Basic Information List
Table Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Neurological Disorder Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Neurological Disorder Drugs Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Neurological Disorder Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Neurological Disorder Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
Table Major Buyers of Neurological Disorder Drugs
Table Distributors/Traders List
Figure Germany Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Neurological Disorder Drugs Sales Forecast by Type (2016-2021)
Table Europe Neurological Disorder Drugs Sales Forecast by Application (2016-2021)